AI assistant
CONMED Corp — Director's Dealing 2014
Sep 15, 2014
31971_dirs_2014-09-15_3e05c405-f7b6-41c3-a0a4-2a42e3e53606.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-09-11
Reporting Person: MANDIA STEPHEN (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-11 | Rsus (restricted Stock Units) | $0 | A | 3000 | Acquired | 2024-09-11 | Common Stock (3000) | Direct |
| 2014-09-11 | Sars (Stock Appreciation Rights) | $39.64 | A | 1000 | Acquired | 2024-09-11 | Common Stock (1000) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting upon completion of the term of service.
F2: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service.